https://www.forbes.com/sites/joshuacohen/2023/08/01/as-medicare-broadens-coverage-of-alzheimers-disease-drug-leqembi-details-emerge-regarding-what-access-entails/
As CMS expands coverage of Leqembi it’s unclear how patient registries will work, how comprehensive scan coverage will be, and whether local carriers have any discretion.
Create an account or login to join the discussion